Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04973163
Title A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP | BEL

Facility Status City State Zip Country Details
Mary Crowley Cancer Research Center Dallas Texas 75201 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Brussels - HOSP Jules Bordet Anderlecht/Brussels-Capital 1070 Belgium Details
Edegem - UNIV UZ Antwerpen Edegem/Antwerpen 2650 Belgium Details
UNIV UZ Gent Gent/Oost-Vlaanderen 9000 Belgium Details
UZ Leuven Leuven/Vlaams-Brabant 3000 Belgium Details
Hospital Vall d'Hebron Barcelona 08035 Spain Details
The Christie Hospital Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field